
Markets
NeuroSense Therapeutics Ltd (NRSN) EPS is poised to hit -0.22 next quarter: How Investors Can Make It Count the Most?
NeuroSense Therapeutics Ltd (NASDAQ: NRSN) flaunted slowness of -10.00% at $1.98, as the Stock market unbolted on Thursday, before settling in for the price of